e-learning
resources
Virtual 2020
Pre-Congress Content
Clinical aspects of idiopathic pulmonary fibrosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The burden of Idiopathic Pulmonary Fibrosis (IPF): a multimodal study of prevalence, healthcare utilization and survival
W. Chia (Kirkcaldy, United Kingdom), F. Harrison (Kirkcaldy, United Kingdom), T. Hartley (Kirkcaldy, United Kingdom), D. Szapiro (Kirkcaldy, United Kingdom), D. Dhasmana (Kirkcaldy, United Kingdom)
Source:
Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Session:
Clinical aspects of idiopathic pulmonary fibrosis
Session type:
E-poster session
Number:
767
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Chia (Kirkcaldy, United Kingdom), F. Harrison (Kirkcaldy, United Kingdom), T. Hartley (Kirkcaldy, United Kingdom), D. Szapiro (Kirkcaldy, United Kingdom), D. Dhasmana (Kirkcaldy, United Kingdom). The burden of Idiopathic Pulmonary Fibrosis (IPF): a multimodal study of prevalence, healthcare utilization and survival. 767
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Incidence and prevalence of IPF in an insurance claims database: Assessing accuracy using medical records
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
The burden of idiopathic pulmonary fibrosis reported by patients and carers in Ireland
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Clinical characteristics of patients with Idiopathic pulmonary fibrosis in a tertiary care center of a developing country
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
The epidemiologic features and the patterns of medical resource use in idiopathic pulmonary fibrosis (IPF) in Korea
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Long-term survival analysis: Pirfenidone compared to standard care for the treatment of patients with idiopathic pulmonary fibrosis
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014
The lived experience of idiopatic pulmonary fibrosis: A qualitative study
Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences
Year: 2016
Idiopathic pulmonary fibrosis: Gender differences in survival and functional decline. A retrospective study
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Do physicians in primary health care recognize pulmonary fibrosis?
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Predicting life expectancy for pirfenidone and best supportive care (BSC) in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF treatment II
Year: 2016
The efficacy of a walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). A pilot study
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Review of care in patients dying of pulmonary fibrosis in a district general hospital
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Incidence of idiopathic pulmonary fibrosis in Italy. Analysis of hospital admission and mortality databases of a large Italian region
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Incidence and resource utilisation of pulmonary exacerbations in patients with cystic fibrosis in the UK
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010
Clinical burden of idiopathic pulmonary fibrosis (IPF): physician and patient perception
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020
The development of a measure to better understand patient experiences with pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Health status & impact of living with idiopathic pulmonary fibrosis (IPF): UK & Ireland Delphi survey
Source: International Congress 2016 – IPF clinical
Year: 2016
IPF Care, a support program for patients with idiopathic pulmonary fibrosis in the UK
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us?
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Median survival in unselected patients with idiopathic pulmonary fibrosis in the United Kingdom
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept